TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.

E Van Cutsem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.